Cellebrite Completes Acquisition of Drone Forensics Leader SCG Canada, Inc.

Rhea-AI Summary

Cellebrite (NASDAQ: CLBT) completed its acquisition of SCG Canada, Inc. on March 2, 2026, adding hand-held UAV/drone forensic capabilities that access data from more than 80 common UAVs.

The integration extends Cellebrite's AI-powered platform to drone flight logs, video and other mission-critical artifacts; financial terms were not disclosed.

Positive

• UAV capability covering extraction from 80+ common drone models
• New data source (flight logs, video, cell-tower connections) to enrich AI analytics
• Hand-held portability enables rapid field extraction and faster decision making

Negative

• Financial terms of the acquisition were not disclosed
• Company highlighted risks including technology pace, regulatory constraints and misuse of solutions

News Market Reaction – CLBT

+1.20%

1 alert

+1.20% News Effect

On the day this news was published, CLBT gained 1.20%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Supported UAV models: more than 80 UAVs

1 metrics

Supported UAV models more than 80 UAVs SCG Canada hand-held digital forensics solution

Market Reality Check

Price: $13.74 Vol: Volume 1,107,540 is below...

low vol

$13.74 Last Close

Volume Volume 1,107,540 is below the 20-day average of 2,449,722 shares, suggesting subdued pre-news trading interest. low

Technical Shares at 13.34 are trading below the 200-day MA of 16.54 and 36.05% under the 52-week high of 20.86.

Peers on Argus

CLBT was down 3.05% with mixed peer action: AVPT down 2.57%, while BOX, CALX, PA...

CLBT was down 3.05% with mixed peer action: AVPT down 2.57%, while BOX, CALX, PAY and QLYS showed modest gains between 0.38% and 1.81%, pointing to a stock-specific move rather than a broad software rotation.

Previous Acquisition Reports

1 past event · Latest: Jun 05 (Positive)

Same Type Pattern 1 events

Date	Event	Sentiment	Move	Catalyst
Jun 05	Acquisition announcement	Positive	+1.1%	Announced Corellium acquisition to add Arm-based virtualization capabilities.

Pattern Detected

Past acquisition news for CLBT has been followed by a modestly positive price reaction.

Recent Company History

Over the last year, Cellebrite has used acquisitions to expand its AI-powered digital investigation platform. A prior deal to acquire Corellium on Jun 05, 2025 combined Arm-based virtualization with Cellebrite’s solutions and saw a 1.08% positive move. Today’s completion of the SCG Canada drone forensics acquisition fits this pattern of adding specialized data sources and capabilities to support defense, intelligence and public safety customers.

Historical Comparison

+1.1% avg move · Past acquisition news (e.g., Corellium) produced an average move of 1.08%, suggesting historically m...

acquisition

+1.1%

Average Historical Move acquisition

Past acquisition news (e.g., Corellium) produced an average move of 1.08%, suggesting historically modest but positive reactions when CLBT expands its digital investigation capabilities via M&A.

Cellebrite has progressed from acquiring Corellium’s Arm-based virtualization to completing the SCG drone forensics deal, broadening its AI-powered investigation platform across mobile, virtualization and unmanned aerial vehicle data sources.

Market Pulse Summary

This announcement completes Cellebrite’s acquisition of SCG Canada, adding hand-held drone forensics...

Analysis

This announcement completes Cellebrite’s acquisition of SCG Canada, adding hand-held drone forensics that access data from over 80 UAV models. It follows earlier M&A steps such as Corellium to deepen AI-powered digital investigations across new data sources. Investors may monitor how quickly these drone capabilities are integrated, the impact on public safety and defense customers, and future disclosures on financial contributions from the combined platform.

Key Terms

unmanned aerial vehicle, uav, digital forensics, ai-powered, +3 more

7 terms

unmanned aerial vehicle technical

"Addition of Unmanned Aerial Vehicle (UAV) forensic capabilities extends Cellebrite's..."

An unmanned aerial vehicle, often called a drone, is a flying device operated without a human pilot onboard, typically controlled remotely or through automated systems. It is used for various purposes such as surveillance, delivery, and data collection. For investors, understanding unmanned aerial vehicles is important because they represent a growing technology with potential applications across many industries, influencing market opportunities and innovation.

uav technical

"provider of hand-held digital forensics solutions that enable access to more than 80 of the most common UAVs."

An unmanned aerial vehicle (UAV) is an aircraft that flies without a pilot on board, controlled remotely or by onboard software like a self-driving car. Investors care because UAVs are used across industries—delivery, agriculture, inspection, mapping, and defense—so demand, regulation, or technological advances can quickly affect revenue and costs for companies that make, operate, or rely on them. Think of a UAV as a robotic helper in the sky whose growing use can change market opportunities and risks.

digital forensics technical

"a leading provider of hand-held digital forensics solutions that enable access..."

Digital forensics is the process of collecting, preserving and analyzing electronic evidence from computers, phones or networks to understand what happened during a breach, fraud or other cyber incident. Think of it as a detective examining a crime scene but for digital devices; it helps pinpoint the cause, scope and timeline of an event. Investors care because findings affect a company’s legal exposure, repair costs, regulatory penalties and public trust, all of which can change the value of an investment.

ai-powered technical

"extends Cellebrite's AI-powered platform to one of the fastest-growing data sources..."

"AI-powered" describes technology that uses artificial intelligence to perform tasks, make decisions, or analyze information automatically. It’s similar to having a highly skilled assistant that can learn from data, recognize patterns, and improve over time, helping to make processes faster and more accurate. For investors, this means better insights and more efficient operations, potentially leading to smarter investment choices.

forward-looking statements regulatory

"This document includes "forward-looking statements" within the meaning of the "safe harbor"..."

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

form 20-f regulatory

"set forth in the section titled "Risk Factors" in Cellebrite's annual report on Form 20-F filed with the SEC..."

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

anti-money-laundering regulatory

"risks associated with Cellebrite's failure to comply with anti-corruption, trade compliance, anti-money-laundering and economic sanctions laws..."

Anti-money-laundering covers the rules, checks and systems used by banks, brokers and regulators to detect, stop and report attempts to hide or move proceeds from crime or to evade sanctions. Investors should care because robust controls protect market integrity, reduce risks of fines, frozen accounts and reputational damage, and affect a company’s costs and ability to do business — like a security checkpoint that helps keep the marketplace safe and reliable.

AI-generated analysis. Not financial advice.

Addition of Unmanned Aerial Vehicle (UAV) forensic capabilities extends Cellebrite's AI-powered platform to one of the fastest-growing data sources in defense and public safety

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 2, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, closed its acquisition of SCG Canada, Inc., a leading provider of hand-held digital forensics solutions that enable access to more than 80 of the most common UAVs. SCG's solution enables extraction, decoding and visualization of millions of data points from drones that often become key forensic artifacts.

Use of drones has continued to expand globally across the defense, intelligence, law enforcement and commercial sectors. At the same time, drones are increasingly used for malicious activity by bad actors. Drones produce a massive number of data points, including flight logs, video files, cell tower connections and many more. SCG's solution enables rapid access and visualization of mission-critical data at the point of collection, for quick decisions that can save lives. SCG's powerful drone forensic data extraction capability creates an additional new, rich data source to help power Cellebrite AI, driving better intelligence outcomes for customers. The device's hand-held portability also presents an opportunity to leverage Cellebrite's AI for enhanced decision making in the field where speed is essential. For more insights into the drone market and the strategic rationale behind Cellebrite's acquisition, visit here.

"Accessing drone data adds major value to our customers and further amplifies the impact of Cellebrite's AI-powered platform for multi-data source analysis, a critical component of modern-day investigations and intelligence gathering," said Thomas E. Hogan, Cellebrite's chief executive officer. "We are excited to have SCG on board and are thrilled to hear our customers' enthusiasm of this added capability in support of their missions to enable a safer world."

"We are still just scratching the surface when it comes to what drone data can tell us," said Brent Salo, SCG's founder and Cellebrite's new vice president of drone forensics. "Cellebrite is the perfect home for SCG, as the Company is already a trusted partner and leader in the defense, intelligence and public safety communities."

Financial terms of the deal were not disclosed.

References to Websites and Social Media Platforms
References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release.

Caution Regarding Forward Looking Statements
This document includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "will," "appear," "approximate," "foresee," "might," "possible," "potential," "believe," "could," "predict," "should," "could," "continue," "expect," "estimate," "may," "plan," "outlook," "future" and "project" and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include, but are not limited to, the growth of the drone market, the value of drone data and customer interest and enthusiasm in the Company's drone forensics are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Cellebrite's ability to keep pace with technological advances and evolving industry standards; Cellebrite's material dependence on the purchase, acceptance and use of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite's digital investigation solutions; Cellebrite's failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; intense competition in all of Cellebrite's markets; the inadvertent or deliberate misuse of Cellebrite's solutions; failure to manage its growth effectively; Cellebrite's ability to introduce new solutions and add-ons; Cellebrite's dependency on its customers renewing their subscriptions and purchasing new subscriptions; the low volume of business Cellebrite conducts via e-commerce; risks associated with the use of artificial intelligence; the risk of requiring additional capital to support the growth of its business; risks associated with Cellebrite's dependency on third parties for supplying components or services and with higher costs or unavailability of materials used to create its hardware product components; lengthy sales cycle for some of Cellebrite's solutions; near term declines in new or renewed agreements; risks associated with inability to recruit, train and retain qualified personnel and senior management; the security of Cellebrite's operations and the integrity of its software solutions against cyber-attacks, information technology system breaches or disruptions; risks associated with the negative publicity related to Cellebrite's business and use of its products; risks related to Cellebrite's intellectual property; the regulatory constraints to which Cellebrite is subject; risks associated with Cellebrite's operations in Israel, including the ongoing Israel-Hamas war, the increased tension between Israel and Iran and its proxies, including the ongoing hostilities between Israel and Hezbollah, and the risk of a greater regional conflict; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer and an emerging growth company; market volatility in the price of Cellebrite's shares; changing tax laws and regulations; risks associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite's significant international operations, including due to fluctuations in foreign currency exchange rates, rising global inflation and exposure to regions subject to political or economic instability; risks associated with Cellebrite's failure to comply with anti-corruption, trade compliance, anti-money-laundering and economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite's existing systems, processes, policies, procedures, internal controls and personnel for Cellebrite's current and future operations and reporting needs; and other factors, risks and uncertainties set forth in the section titled "Risk Factors" in Cellebrite's annual report on Form 20-F filed with the SEC on March 18, 2025, and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission ("SEC"), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

About Cellebrite  
Cellebrite's (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite's AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate more than 1.5 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite's technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com, https://investors.cellebrite.com/investors and find us on social media @Cellebrite.

Media   
Victor Cooper  
Sr. Director of Corporate Communications 
Victor.cooper@cellebrite.com   
+1 404.804.5910 

Investor Relations  
Andrew Kramer
Vice President, Investor Relations 
investors@cellebrite.com
+1 973.206.7760 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cellebrite-completes-acquisition-of-drone-forensics-leader-scg-canada-inc-302699890.html

SOURCE Cellebrite

FAQ

What did Cellebrite (CLBT) acquire from SCG Canada on March 2, 2026?

Cellebrite acquired SCG Canada's hand-held drone forensic solution that accesses data from 80+ UAV models. According to the company, the tool extracts, decodes and visualizes flight logs, video and other drone artifacts to support investigations and intelligence operations.

How will the SCG acquisition affect Cellebrite's AI platform and data sources (CLBT)?

The acquisition adds drone-derived data as a new, rich input to Cellebrite's AI-powered analysis platform. According to the company, flight logs, video files and connectivity records will enhance multi-data source intelligence outcomes for customers.

Does the SCG deal include a disclosed purchase price for Cellebrite (CLBT)?

No, financial terms for the acquisition were not disclosed in the announcement. According to the company, it closed the transaction on March 2, 2026, but did not provide deal value or pricing details.

What operational benefits does the hand-held SCG device bring to Cellebrite customers (CLBT)?

The hand-held device enables rapid, point-of-collection extraction and visualization of mission-critical drone data for quick decisions. According to the company, portability supports faster field intelligence where speed can be lifesaving.

What risks did Cellebrite (CLBT) note related to expanding into drone forensics?

Cellebrite highlighted risks such as keeping pace with technology, regulatory constraints and potential misuse of solutions. According to the company, these risks could affect adoption, operations and the safe deployment of drone-forensic capabilities.